CDC42EP3 Antibody

CDC42, a small Rho GTPase, regulates the formation of F-actin-containing structures through its interaction with the downstream effector proteins. The protein encoded by this gene is a member of the Borg family of CDC42 effector proteins. Borg family proteins contain a CRIB (Cdc42/Rac interactive-binding) domain. They bind to, and negatively regulate the function of, CDC42. This protein can interact with CDC42, as well as with the ras homolog gene family, member Q (ARHQ/TC10). Expression of this protein in fibroblasts has been shown to induce pseudopodia formation. [provided by RefSeq]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 2 applications: IHC-P, WB.

Showing Publications 1 - 4 of 4.

Publications using NBP1-88382	Applications	Species
Yang Z, Xu T, Xie T et al. CDC42EP3 promotes glioma progression via regulation of CCND1 Cell death & disease [PMID: 35365622]
Xu P, Li X, Tang C et al. Deduction of CDC42EP3 suppress development and progression of osteosarcoma Experimental Cell Research 2022-01-01 [PMID: 34998812] (WB, IHC-P, Human)	WB, IHC-P	Human
Chen W, Zhu Y, Zhang W et al. CDC42EP3 is a key promoter involved in the development and progression of gastric cancer Carcinogenesis 2021-06-10 [PMID: 34111280]
Zhang C, Shen Y, Gao L et al. Targeting POLE2 Creates a Novel Vulnerability in Renal Cell Carcinoma via Modulating Stanniocalcin 1 Frontiers in Cell and Developmental Biology 2021-02-11 [PMID: 33644060] (WB, Human)	WB	Human

Array NBP1-88382

• CDC42EP3 Antibodies
• CDC42EP3 Lysate
• CDC42EP3 Proteins